[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353231-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353231-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deep-learning-of-pretreatment-ascites-cytopathology-for-platinum-resistance-risk-stratification-in-advanced-epithelial-ovarian-cancer","Deep learning of pretreatment ascites cytopathology for platinum-resistance risk stratification in advanced epithelial ovarian cancer","","Platinum resistance drives poor outcomes in advanced epithelial ovarian cancer, yet dependable pre-treatment predictors are limited. Pretreatment ascites cytology reflects the peritoneal tumor microenvironment, but its cytomorphology has not been systematically used for treatment-response prediction. OVCAP, a multi-scale deep-learning framework, analyzes pretreatment ascites cytology whole-slide images in 438 FIGO IIIB–IV patients and is validated across internal and independent external cohorts. The model identifies high-risk morphologic patterns and links them to underlying biology using attention-guided review and integrated single-cell RNA sequencing, supporting early clinical risk stratification before first-line platinum therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deep-learning-of-pretreatment-ascites-cytopathology-for-platinum-resistance-risk-stratification-in-advanced-epithelial-ovarian-cancer/353231/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deep-learning-of-pretreatment-ascites-cytopathology-for-platinum-resistance-risk-stratification-in-advanced-epithelial-ovarian-cancer/353231.png","ImageObject",300,407,{"name":42,"@type":43},"Well Done","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is early prediction of platinum resistance important in advanced epithelial ovarian cancer?","Question",{"text":63,"@type":64},"Platinum resistance is a major determinant of poor outcomes. Reliable predictors before treatment are scarce, and the choice of initial therapy must account for platinum responsiveness at an early stage.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is OVCAP and what data does it use?",{"text":68,"@type":64},"OVCAP is a multi-scale deep-learning framework that analyzes pretreatment ascites cytology whole-slide images to estimate platinum-resistance risk.",{"name":70,"@type":61,"acceptedAnswer":71},"How did OVCAP perform compared with the KELIM score?",{"text":72,"@type":64},"OVCAP achieved ROC-AUC values of 0.894, 0.863, and 0.828 in internal and two independent external validation cohorts, outperforming the KELIM score with an AUC of 0.619.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353231,1790189427,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892210082,"https://ap-avatar.wpscdn.com/avatar/56001069da27c9f41e8?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789614185077863061","Neoplasia 79 (2026) 101330  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Original Research\u003Cbr>Deep learning of pretreatment ascites cytopathology for\u003Cbr>platinum-resistance risk stratification in advanced epithelial ovarian cancer |  |  | |\n| --- | --- | --- | --- |\n| Yangyang Zhang a,b,1, Xiaochun Wan b,c,d,1, Yongqi Chena,b,1 , Jianbo Xu e,1,\u003Cbr>Weijie Wang e, Haiming Lib,f, Zhihao Zhang b,f, Yi-Hua Luog, Liu Wang a,b, Xingzhu Ju a,b, Xiaohua Wu a,b,*, Zilong Wang h,*, Bo Pingb,c,d,*, Qinhao Guo a,b,*\u003Cbr>a Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China\u003Cbr>c Department of Pathology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China d Institute of Pathology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China e Northern Jiangsu People's Hospital, Yangzhou, 225001, Jiangsu, China\u003Cbr>f Department of Radiology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China\u003Cbr>g The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200030, China h Microsoft Research Asia, Shanghai 200232, China |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Advanced epithelial ovarian cancer Ascites cytopathology\u003Cbr>Platinum resistance Deep learning Computational pathology |  | Background: Platinum resistance is a major determinant of poor outcome in advanced epithelial ovarian cancer, yet reliable predictors available before treatment initiation remain scarce. Ascitic fluid is commonly obtained during diagnostic work-up and directly reflects the peritoneal tumour microenvironment, but its cytomorphological information has not been systematically exploited for treatment-response prediction.\u003Cbr>Methods: We present OVCAP, a multi-scale deep-learning framework that analyses pretreatment ascites cytology whole-slide images to estimate platinum-resistance risk. The study included 438 patients with FIGO stage IIIB–IV epithelial ovarian cancer. Model performance was evaluated in one internal and two independent external validation cohorts. Attention-guided cytopathology review was performed to identify high-risk morphologic patterns, and integrated single-cell RNA sequencing analyses were used to characterise the underlying biological features.\u003Cbr>Results: OVCAP achieved area under the receiver operating characteristic curve (ROC-AUC) values of 0.894, 0.863, and 0.828 in the internal and two independent external validation cohorts, respectively, and outperformed the KELIM score (AUC 0.619). Attention-guided cytopathology review identified recurrent high-risk morphologic patterns in resistant disease: epithelial cytoplasmic vacuolization and interaction-rich malignant aggregates accompanied by immune and mesothelial cells. Integrated single-cell analyses linked these phenotypes to membrane remodelling, lipid reprogramming, hypoxia-associated stress signalling, and reinforced adhesion and immunoregulatory networks.\u003Cbr>Conclusion: These findings support pretreatment ascites cytology as a clinically accessible substrate for early risk stratification before first-line platinum-based therapy. |  |\n\nIntroduction  \nOvarian cancer remains one of the most lethal gynaecologic malignancies, with most patients presenting at advanced stages due to ineffective screening and non-specific early symptoms [1,2]. In this setting, first-line management typically involves either primary debulking  \nsurgery (PDS) followed by platinum-based chemotherapy or neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS) [3]. While randomized trials have reported similar overall surviva","cbCaikXiCE76m0X4","https://ap.wps.com/l/cbCaikXiCE76m0X4","pdf",5987557,11,"English","# Introduction\n## Clinical need for early predictors of platinum response\n# Methods\n## OVCAP deep-learning framework\n## Cohorts and validation strategy\n# Results\n## ROC-AUC performance across cohorts\n## High-risk morphologic patterns and biological features\n# Conclusion","[{\"question\":\"Why is early prediction of platinum resistance important in advanced epithelial ovarian cancer?\",\"answer\":\"Platinum resistance is a major determinant of poor outcomes. Reliable predictors before treatment are scarce, and the choice of initial therapy must account for platinum responsiveness at an early stage.\"},{\"question\":\"What is OVCAP and what data does it use?\",\"answer\":\"OVCAP is a multi-scale deep-learning framework that analyzes pretreatment ascites cytology whole-slide images to estimate platinum-resistance risk.\"},{\"question\":\"How did OVCAP perform compared with the KELIM score?\",\"answer\":\"OVCAP achieved ROC-AUC values of 0.894, 0.863, and 0.828 in internal and two independent external validation cohorts, outperforming the KELIM score with an AUC of 0.619.\"}]","Deep learning of pretreatment ascites cytopathology for platinum-resistance risk stratification in advanced epithelial ovarian cancer | PDF",1790103726,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf56bf43588d52e9c505ceac10b9dc05.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52d1f2296eb017a96abbc78eeb582832.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9b58dcba175f5e2d88866b8228b0750.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/178017af49e68fca177d62c9db083f37.webp",980,1306]